Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsInvestigators examined whether mineralocorticoid receptor antagonists can ameliorate glucocorticoid receptor-mediated skin barrier dysfunction in normal human epidermal keratinocytes, reconstructed human epidermis, and subjects under psychological stress.
[Scientific Reports]
7753456 2KF284DV items 1 apa 0 default asc 1 163112 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-6b25ac46c19a7c5b4520a446cb47d1b2%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%222KF284DV%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lee%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELee%2C%20H.%2C%20Choi%2C%20E.-J.%2C%20Kim%2C%20E.%20J.%2C%20Son%2C%20E.%20D.%2C%20Kim%2C%20H.-J.%2C%20Park%2C%20W.-S.%2C%20Kang%2C%20Y.-G.%2C%20Shin%2C%20K.-O.%2C%20Park%2C%20K.%2C%20Kim%2C%20J.-C.%2C%20Kim%2C%20S.-N.%2C%20%26amp%3B%20Choi%2C%20E.%20H.%20%282021%29.%20A%20novel%20mineralocorticoid%20receptor%20antagonist%2C%207%2C3%26%23x2019%3B%2C4%26%23x2019%3B-trihydroxyisoflavone%20improves%20skin%20barrier%20function%20impaired%20by%20endogenous%20or%20exogenous%20glucocorticoids.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%2011920.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-91450-6%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-91450-6%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3D2KF284DV%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20novel%20mineralocorticoid%20receptor%20antagonist%2C%207%2C3%27%2C4%27-trihydroxyisoflavone%20improves%20skin%20barrier%20function%20impaired%20by%20endogenous%20or%20exogenous%20glucocorticoids%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanil%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eun-Jeong%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eun%20Jung%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eui%20Dong%22%2C%22lastName%22%3A%22Son%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyoung-June%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Seok%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Young-Gyu%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyong-Oh%22%2C%22lastName%22%3A%22Shin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyungho%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jin-Chul%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su-Nam%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eung%20Ho%22%2C%22lastName%22%3A%22Choi%22%7D%5D%2C%22abstractNote%22%3A%22Excess%20glucocorticoids%20%28GCs%29%20with%20either%20endogenous%20or%20exogenous%20origins%20deteriorate%20skin%20barrier%20function.%20GCs%20bind%20to%20mineralocorticoid%20and%20GC%20receptors%20%28MRs%20and%20GRs%29%20in%20normal%20human%20epidermal%20keratinocytes%20%28NHEKs%29.%20Inappropriate%20MR%20activation%20by%20GCs%20mediates%20various%20GC-induced%20cutaneous%20adverse%20events.%20We%20examined%20whether%20MR%20antagonists%20can%20ameliorate%20GC-mediated%20skin%20barrier%20dysfunction%20in%20NHEKs%2C%20reconstructed%20human%20epidermis%20%28RHE%29%2C%20and%20subjects%20under%20psychological%20stress%20%28PS%29.%20In%20a%20preliminary%20clinical%20investigation%2C%20topical%20MR%20antagonists%20improved%20skin%20barrier%20function%20in%20topical%20GC-treated%20subjects.%20In%20NHEKs%2C%20cortisol%20induced%20nuclear%20translocation%20of%20GR%20and%20MR%2C%20and%20GR%20and%20MR%20antagonists%20inhibited%20cortisol-induced%20reductions%20of%20keratinocyte%20differentiation.%20We%20identified%207%2C3%5Cu2019%2C4%5Cu2019-trihydroxyisoflavone%20%287%2C3%5Cu2019%2C4%5Cu2019-THIF%29%20as%20a%20novel%20compound%20that%20inhibits%20MR%20transcriptional%20activity%20by%20screening%2030%20cosmetic%20compounds.%207%2C3%5Cu2019%2C4%5Cu2019-THIF%20ameliorated%20the%20cortisol%20effect%20which%20decreases%20keratinocyte%20differentiation%20in%20NHEKs%20and%20RHE.%20In%20a%20clinical%20study%20on%20PS%20subjects%2C%207%2C3%27%2C4%27-THIF%20%280.1%25%29-containing%20cream%20improved%20skin%20barrier%20function%2C%20including%20skin%20surface%20pH%2C%20barrier%20recovery%20rate%2C%20and%20stratum%20corneum%20lipids.%20In%20conclusion%2C%20skin%20barrier%20dysfunction%20owing%20to%20excess%20GC%20is%20mediated%20by%20MR%20and%20GR%3B%20thus%2C%20it%20could%20be%20prevented%20by%20treatment%20with%20MR%20antagonists.%20Therefore%2C%20topical%20MR%20antagonists%20are%20a%20promising%20therapeutic%20option%20for%20skin%20barrier%20dysfunction%20after%20topical%20GC%20treatment%20or%20PS.%22%2C%22date%22%3A%222021-06-07%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-91450-6%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41598-021-91450-6%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%22DUPVZUHA%22%5D%2C%22dateModified%22%3A%222021-06-07T16%3A45%3A32Z%22%7D%7D%5D%7D
Lee, H., Choi, E.-J., Kim, E. J., Son, E. D., Kim, H.-J., Park, W.-S., Kang, Y.-G., Shin, K.-O., Park, K., Kim, J.-C., Kim, S.-N., & Choi, E. H. (2021). A novel mineralocorticoid receptor antagonist, 7,3’,4’-trihydroxyisoflavone improves skin barrier function impaired by endogenous or exogenous glucocorticoids. Scientific Reports, 11(1), 11920. https://doi.org/10.1038/s41598-021-91450-6 Cite
